ArticleOncotarget2015

Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.

Chetna Sharon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.